Skip to content
10-Q

Quarterly Report

Q BIOMED INC.

0001104659-21-092603

← back to feed
Filed
Jul 15, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jul 9, 2021 27.59M sh
Cash And Equivalents Q2 2021 · May 31, 2021 $290.43K
Cash And Equivalents Q2 2021 · Nov 30, 2020 $177.15K
Cash And Equivalents Q2 2021 · May 31, 2020 $3.02M
Cash And Equivalents Q2 2021 · Nov 30, 2019 $172.64K
Current Liabilities Q2 2021 · May 31, 2021 $2.98M
Current Liabilities Q2 2021 · Nov 30, 2020 $1.7M
Total Liabilities Q2 2021 · May 31, 2021 $2.98M
Total Liabilities Q2 2021 · Nov 30, 2020 $1.7M
Current Assets Q2 2021 · May 31, 2021 $410.02K
Current Assets Q2 2021 · Nov 30, 2020 $223.48K
Total Assets Q2 2021 · May 31, 2021 $785.02K
Total Assets Q2 2021 · Nov 30, 2020 $623.48K
Operating Cash Flow Q2 2021 · May 31, 2020 −$3.07M
Stockholders Equity Q2 2021 · May 31, 2020 $2.11M
Stockholders Equity Q2 2021 · Feb 29, 2020 −$5.23M
Stockholders Equity Q2 2021 · Nov 30, 2019 −$5.05M
Rd Expense Q2 2021 · May 31, 2020 $20.33K
Rd Expense Q2 2021 · May 31, 2020 $283.2K
Net Income Q2 2021 · May 31, 2020 −$1.86M
Net Income Q2 2021 · May 31, 2020 −$7.8M
Gross Profit Q2 2021 · May 31, 2020 −$19.7K
Gross Profit Q2 2021 · May 31, 2020 −$19.7K
Cost Of Revenue Q2 2021 · May 31, 2020 $34.7K
Cost Of Revenue Q2 2021 · May 31, 2020 $34.7K
Revenue Q2 2021 · May 31, 2020 $15K
Revenue Q2 2021 · May 31, 2020 $15K